Funder
National Natural Science Foundation of China
The Net construction of human genetic resource Bio-bank in North China
Tianjin Science and Technology Committee Foundation
National Human Genetic Resources Sharing Service Platform
Changjiang Scholars and Innovative Research Team in University in China
Tianjin Municipal Key Health Research Program
National Key Research and Development Program of China
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference32 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
2. Li H, Zheng RS, Zhang SW, Zeng HM, Sun KX, Xia CF, et al. Incidence and mortality of female breast cancer in China, 2014. Zhonghua Zhong Liu Za Zhi. 2018;40(3):166–71.
3. Campbell HE, Gray AM, Harris AL, Briggs AH, Taylor MA. Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK. Br J Cancer. 2010;103(6):776–86.
4. Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat. 2008;107(3):309–30.
5. Perey L, Hayes DF, Maimonis P, Abe M, O'Hara C, Kufe DW. Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res. 1992;52(9):2563–8.
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献